Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Bloom MD vs NowPatient

Bloom MD costs $824 less a month, and both sell tirzepatide and liraglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Bloom MD logo

Bloom MD

7.0
★★★★☆3.5/5

Best for: starting below a standard dose, with microdose tiers

Visit Bloom MD →
VS
NowPatient logo

NowPatient

6.1
★★★☆☆3.1/5

Best for: an oral route if you will not self-inject

Visit NowPatient →

If you are choosing between Bloom MD and NowPatient, the first difference is cost: Bloom MD is $824 a month cheaper at the entry price. Both prescribe tirzepatide and liraglutide, so moving from one to the other would not change your drug. Bloom MD leads our six-part score, 7.0 to 6.1.

Bloom MD vs NowPatient price

Bloom MD is the cheaper way in: $245 a month against $1,069 a month at NowPatient. That is $824 less each month (77% lower), or about $9,888 over a year of treatment.

Drug by drug: Tirzepatide is cheaper at Bloom MD ($245 a month vs $1,069 a month); liraglutide is cheaper at Bloom MD ($395 a month vs $1,349 a month).

Medications and formats

Both sell tirzepatide and liraglutide; only NowPatient lists semaglutide.

On format, Bloom MD prices compounded injections, while NowPatient prices brand-name pens.

If you want the FDA-approved brand rather than a compounded version, NowPatient is the only one of the two with a brand-name price.

Where each one treats patients

Neither Bloom MD nor NowPatient publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Bloom MD

Monthly subscription (Any Dose)Compounded
$295/mo
semaglutide

Flat 'Any Dose' monthly. Also 90-day $750; 10-week new-patient starter $395.

30-Day starting (2.2mg)Compounded
$295/mo
tirzepatide

Scales by dose: 4.4mg $395, 7mg $445, 10mg $495, 13mg $595. 90-day plans $775–$1,385.

Monthly (from)Compounded
$395/mo
liraglutide

From $395/mo, scales to $595.

Microdose monthlyCompounded
$245/mo
tirzepatide

Microdose GLP-1 (tirzepatide).

Oral drops monthlyoral
$245/mo
GLP-1 (oral)

Oral GLP-1 drops.

Pill program membershiporal
$75/mo
Foundayo / Wegovy oral

Membership only — the $75/mo does NOT include the cost of the medication.

NowPatient

Mounjaro (brand, cash-pay)Brand-name
$1069/mo
tirzepatide
Wegovy injection (brand, cash-pay)Brand-name
$1349/mo
semaglutide
Wegovy oral tablet (brand, cash-pay)Brand-name
$1349/mo
semaglutide
Saxenda (brand, cash-pay)Brand-name
$1349/mo
liraglutide

What each price covers

NowPatient's price also covers the clinician visit and the medication itself, which Bloom MD does not claim.

Bloom MD does not say what its price includes.

NowPatient is silent on shipping, lab work and coaching.

That matters most for the drug: unless Bloom MD confirms otherwise, budget for medication on top of its listed price.

Bloom MD

Inclusions not disclosed.

NowPatient

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Bloom MD scores 7.0 and NowPatient 6.1 out of 10.

Bloom MD is stronger on user experience (8.0 vs 2.5) and trust & safety (6.5 vs 4.0).

NowPatient is stronger on value (6.1 vs 5.1) and support (5.5 vs 5.0).

Effectiveness and accessibility are within half a point.

How we score

Bloom MD

7.0/10

Overall

NowPatient

6.1/10

Value25%

5.1A
vs
B
6.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

6.5A
vs
B
4.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.5

FDA warning letters

Neither Bloom MD nor NowPatient has an FDA warning letter on record with us.

Features & Coverage

FeatureBloom MDNowPatient
Starting Price✓$245/mo$1,069/mo
Features0 features✓2 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes—
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Bloom MD

Weight loss, longevity, and wellness are the lines Bloom MD advertises. GLP-1 treatment is part of its weight-loss line; product details and prices sit inside its online store.

Read our full Bloom MD review →

About NowPatient

Nothing is charged for the consultation at NowPatient; the medication is the whole bill. Because the out-of-pocket cost tracks brand list prices, an uninsured patient faces roughly $1,000-$1,350/mo. Access is to brand-name GLP-1s for weight management: Saxenda is on the menu, so is Mounjaro, and Wegovy comes as an injection and as an oral tablet. The company spans the US and UK, HQ Austin, TX.

Read our full NowPatient review →

Pros & Cons

Bloom MD

What we like

  • Tirzepatide costs $245 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • We found no FDA warning letters issued to Bloom MD

Watch-outs

  • Semaglutide costs $295 a month, 59% above the $185 median for compounded semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its liraglutide, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

NowPatient

What we like

  • Tirzepatide costs $1069 a month, 14% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • The monthly price includes the medication and clinician visits
  • We found no FDA warning letters issued to NowPatient
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • Semaglutide costs $1349 a month, 35% above the $997 median for brand-name semaglutide across the sellers we compare
  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Bloom MD

Bloom MD wins this one, 7.0 to 6.1, above all for starting below a standard dose, with microdose tiers. It also costs $824 less each month than NowPatient. NowPatient fits better if an oral route if you will not self-inject is your priority.

Choose Bloom MD if…

You want starting below a standard dose, with microdose tiers and an opening price near $245 a month.

Choose NowPatient if…

You want an oral route if you will not self-inject and an opening price near $1,069 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Luvo Health

Moving between compounded and brand without changing seller

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

Bloom MD vs NowPatient: FAQ

Bloom MD. It starts at $245 a month; NowPatient starts at $1,069 a month, $824 more per month.
Yes, both sell tirzepatide and liraglutide. NowPatient adds semaglutide.
Bloom MD does not publish where it ships; NowPatient does not publish where it ships. Confirm your state before paying.
Only NowPatient includes the clinician visit and the medication itself.
Bloom MD has none. NowPatient has none.
No. Neither Bloom MD nor NowPatient pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.